The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension. - Wikidata - awgldk - TriplyDB

The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.

The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.

http://www.wikidata.org/entity/Q37791311

about

Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.The use of lisdexamfetamine dimesylate for the treatment of ADHD.The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.The safety of extended-release drug formulations for the treatment of ADHD.New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability.Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists.Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity Disorder.Methylphenidate HCL for the treatment of ADHD in children and adolescents.

P2860

Q28393582-7443888F-BC60-43D2-AA60-F3090BC5019C Q36968227-26E4FAC4-4A25-4AA8-8C58-F20C07BB685B Q37960505-7FC199CB-1B0F-4360-90C6-C30D70D5FE3F Q37975550-DFDEDE7B-3137-44DA-8075-419EFC173888 Q38140019-1BF6E2AD-C705-40E2-992B-9FA7D59FD7A2 Q38732635-292A8255-8298-46AE-9A80-D6D02B50B487 Q38764857-C1B9185D-BAB9-4990-AAFB-BF960EFF00CB Q49187017-600C076A-5B4E-42AB-BBC4-23E3DFA6E8A9 Q50578470-4CF09F43-F734-476F-80C1-2412B758674E Q53736992-0B1AFC30-5C8B-48AF-9ACD-D7648F5DCC07

P2860

The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.

http://www.wikidata.org/entity/Q37791311

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@en

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@nl

type

label

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@en

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@nl

prefLabel

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@en

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@nl

P1433

Q37791311-26DA9960-1609-4FBC-B39C-CB228CB6CCF4

P1476

Q37791311-FA02DF24-0648-45CF-8595-1F888F52C734

P2093

Q37791311-7AF02AA1-F61D-4398-ABBB-B2B8CC23FA12

Q37791311-F747A81A-9BB3-4CAE-90FC-D45660603121

P2860

Q37791311-15F7D029-DB38-44BA-AD05-9917EE98DB1A

Q37791311-241FB826-88BA-4F96-914A-04FF19648DF8

Q37791311-3689ABDC-F72C-4B87-B505-88AE11B772EA

Q37791311-7927DE62-B32F-4685-B52F-15D0B3EDA6C0

Q37791311-8E6FEF45-98D0-41CC-944F-9AC4D392447A

Q37791311-981376FB-8CA8-4DE2-8F3F-3D2E636FBE58

Q37791311-C58AA35D-AE75-44C3-9669-7B0FC2623A51

Q37791311-C9CC8C0B-09DE-4BEE-AA10-C2E3FA7D1FE9

Q37791311-DF6BD0D3-2799-42AF-8B56-69878D99C267

Q37791311-E97481B0-3C09-4B4D-BD77-F6ADB71AFED6

P304

Q37791311-468777AA-BEB9-4288-A36C-ECF28E5EE640

P31

Q37791311-3E669655-CD27-492C-A0D8-D35F7CE643A9

P356

Q37791311-DCE19A5E-6FE7-431B-9162-CA078ACC60E0

P407

Q37791311-4F20712C-E505-47FA-A3B9-7218991E2565

P433

Q37791311-2B1AF6D1-3892-4806-B900-0AA362E5951B

P478

Q37791311-1C3D6C9E-5426-44CF-917E-7673B48494A7

P577

Q37791311-7D94D631-962B-462A-AE37-4A9A8F977083

P698

Q37791311-748F7DEF-D879-46E2-9E7D-6EE9CF6E90EF

P356

PGM.2010.09.2199

P1433

Postgraduate Medicine

P1476

The single-dose pharmacokineti ...... thylphenidate oral suspension.

@en

P2093

Ann C Childress

http://www.w3.org/2001/XMLSchema#string

Sally A Berry

http://www.w3.org/2001/XMLSchema#string

P2860

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder.

Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.

Social functioning in predominantly inattentive and combined subtypes of children with ADHD.

Academic and educational outcomes of children with ADHD.

The laboratory school protocol: its origin, use, and new applications.

P304

35-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2010.09.2199

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20861586

http://www.w3.org/2001/XMLSchema#string